instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Quality and Commercial Teams,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. I have two separate matters to raise. F... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recomm... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I am formally reporting two concerns. The ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Issue reported with Product A and institutional contract enquiry
BODY:
Dear Quality Assurance Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the oral syringe provided in the kit had illegible graduation markings making accurate dosing impossible in a specific identified batch... |
SUBJECT: Observation during use of Product A and institutional inquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the clinical pharmacist for a long-term care facility and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory com... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on dose modification f... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Regulatory Affairs,
I am the head of formulary and medicines optimisation for an integrated care board and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 38 year old... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical intervention take... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I need to address two separate issues. Regarding... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide guidance on dose t... |
SUBJECT: Inquiry and feedback about Product A and supply inquiry
BODY:
Dear Medical Director,
I am the prescribing advisor for a mental health trust and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The subject is a 47 year old male with major depress... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Product quality and adverse experience with Product A and institutional contract enquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the medical director of a specialist cardiovascular centre and I am contacting you regarding two separate topics. The first is a product defect report for Product A where th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the batch number on the vial label did not match the corresponding entry in the electronic pedigree system in a specific identified bat... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Medical and Commercial Teams,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection re... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the bottle seal was broken upon receipt and 3 tablets were missing from the blister pack in a specific identified batch with quarantine... |
SUBJECT: Labeling error and clinical query about Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the clinical lead at a geriatric medicine service and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug interactio... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional inquiry
BODY:
Dear Safety Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A whe... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for Product ... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Product Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. and I am writing to formally report two distinct matters. Re... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the bioequivalence data for... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
To Whom It May Concern,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I need to address two separate issues. Regarding Pr... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and b... |
SUBJECT: Joint product evaluation and safety report for Product A and supply inquiry
BODY:
Dear Patient Safety and Market Access Team,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 52 y... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention taken, qualifyin... |
SUBJECT: Administrative and medical query on Product A and institutional inquiry
BODY:
Dear Product Team,
I am the quality officer at a private hospital and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Could you clarify the pregnancy category and any terato... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy category and... |
SUBJECT: Comprehensive inquiry on Product A and institutional contract enquiry
BODY:
Dear Drug Safety and Medical Information,
I am the chief pharmacist at a district general hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 50mg where the child-resista... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the child-resistant cap failed to engage properly, raising serious safety concerns for household storage in a specific identified batch... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Safety Team,
I am the prescribing advisor for a mental health trust and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee is considering intr... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric use, and... |
SUBJECT: Urgent problem regarding Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I am writing to report two separate issues. The first involves ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clini... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. and I am writing to formally raise two matte... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on ... |
SUBJECT: Labeling error and clinical query about Product A and institutional inquiry
BODY:
Dear Patient Support,
I am the chief pharmacist at a district general hospital and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Please provide the recomme... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended storage tempe... |
SUBJECT: Inquiry and feedback about Product A and institutional contract enquiry
BODY:
Dear Clinical Coordinator,
I am the clinical pharmacist for a long-term care facility and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the accomp... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the accompanying patient leaflet was missing entirely from 2 of the 5 cartons delivered in a specific identified batch with quarantined... |
SUBJECT: Urgent concern regarding Product A and institutional inquiry
BODY:
To Whom It May Concern,
I am the clinical pharmacist for a long-term care facility and I have two distinct issues to address. Regarding Product A for formulary evaluation, Can you confirm the shelf life and beyond-use dating for opened vials o... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and beyond-us... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the lead clinical coordinator for a hospice network and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the tablets in th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the tablets in the current batch are a visibly darker shade than all previous batches of the same strength in a specific identified bat... |
SUBJECT: Market access and patient impact of Product A and supply inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 71 year old male ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I wish to raise two issues. The first concerns medical informati... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What monitoring parameters are reco... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am writing to report two separate issues. The firs... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical int... |
SUBJECT: Inquiry and feedback about Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I am contacting y... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Issue reported with Product A and institutional inquiry
BODY:
Dear Clinical Coordinator,
I am the lead clinical pharmacist at a regional oncology unit and I have two distinct issues to address. Regarding Product A for formulary evaluation, Can you clarify whether Product A is indicated as first-line or second... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is indicat... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am writing to formally raise two matters... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Medical Affairs,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I am writing to formally report two disti... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide the pharmacokinetic... |
SUBJECT: Urgent concern regarding Product A and institutional inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the medical director of a specialist cardiovascular centre and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Could you ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy category and... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Compliance Team,
I am writing as the clinical coordinator for a multi-site renal network where Product A is used for anaemia management and Product B for phosphate binding. and I am writing to report two separate issues. The first involves... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clini... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I am writing to report two separate issues. The first involves Product A... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient reported visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, wit... |
SUBJECT: Comprehensive inquiry on Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 50mg where the refill cartridge for th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the refill cartridge for the inhaler device failed to lock into place and fell out upon inversion in a specific identified batch with q... |
SUBJECT: Unexpected reaction linked to Product A and Product B
BODY:
Dear Clinical Affairs,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I need to address two separate issues. Regarding Product A our clinical team r... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric ... |
SUBJECT: Multi-product safety and information request for Product A and institutional inquiry
BODY:
Dear Quality Officer,
I am the chief pharmacist at a district general hospital and I have two distinct issues to address. Regarding Product A for formulary evaluation, Is there any guidance on Product A use in patients ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A use in pa... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I wish to bring two issues to your atte... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dos... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. I have... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinica... |
SUBJECT: Distribution and side-effect profile of Product A and institutional inquiry
BODY:
Dear Quality Officer,
As the head of pharmacy procurement for a regional health trust and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Can you share the p... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-documented outcome... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Product Team,
I am the head of formulary and medicines optimisation for an integrated care board and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 54 year old male with ty... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with clinical in... |
SUBJECT: Labeling error and clinical query about Product A and institutional inquiry
BODY:
Dear Customer Support,
I am the clinical lead pharmacist at a large teaching hospital and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory com... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing interval for ... |
SUBJECT: Multi-faceted problem about Product A and institutional contract enquiry
BODY:
To Whom It May Concern,
I am the head of formulary and medicines optimisation for an integrated care board and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine di... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the temperature indicator strip inside the shipping box had turned irreversibly red, indicating cold-chain breach in a specific identif... |
SUBJECT: Administrative and medical query on Product A and institutional inquiry
BODY:
Dear Quality Assurance Team,
I am the nurse practitioner in a busy GP practice and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Please provide the immunogeni... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity risk asses... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I need to address two separate issues. Regarding Product A... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Pharmacy Director,
I am the nurse practitioner in a busy GP practice and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the temperature indicator strip inside th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the temperature indicator strip inside the shipping box had turned irreversibly red, indicating cold-chain breach in a specific identif... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Medical Information and Safety Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I wish to bring two issues to your at... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on ... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Compliance Team,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. I have two separate issues to raise. The first is a clinical i... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide a summary of clinic... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I am writing to fo... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the mechanism of action for... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Product Team,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. and I wish to bring two issues to your attention. The first is a me... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there a black box warning or regu... |
SUBJECT: Distribution and side-effect profile of Product A and institutional contract enquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the head of formulary and medicines optimisation for an integrated care board and I have two distinct issues to address. The first concerns Product A 25mg where our quality team found... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the oral syringe provided in the kit had illegible graduation markings making accurate dosing impossible in a specific identified batch... |
SUBJECT: Multi-product safety and information request for Product A and institutional inquiry
BODY:
Dear Quality Officer,
As the pharmacy director of a 500-bed tertiary hospital and I am contacting you regarding two separate topics. The first matters clinical guidance on Product A where Are there any contraindications... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for Product ... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Medical Director,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I am contacting you about two separa... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share the patient-reported ... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Product Team,
I am the lead clinical coordinator for a hospice network and I have two distinct issues to address. The first concerns Product A 100mg where our quality team found that the ampoule neck shattered during attem... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the ampoule neck shattered during attempted opening despite following the recommended technique in a specific identified batch with qua... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Healthcare Liaison,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. I have two separate... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Product Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I wish to bring two issues to your attention. Th... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A u... |
SUBJECT: Integrated feedback regarding Product A and institutional contract enquiry
BODY:
Dear Pharmacovigilance Team,
I am the clinical pharmacist for a long-term care facility and I am contacting you regarding two separate topics. The first is a product defect report for Product A where several tablets were chipped ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where several tablets were chipped along the edges and had an off-white discoloration inconsistent with the product specification in a specif... |
SUBJECT: Multi-faceted concern about Product A and institutional contract enquiry
BODY:
Dear Pharmacy Director,
I am the quality officer at a private hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the syringe plunger was stuck and could no... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the syringe plunger was stuck and could not be depressed smoothly, suggesting a manufacturing defect in a specific identified batch wit... |
SUBJECT: Request for details about Product A and supply inquiry
BODY:
Dear Product Team,
I am the prescribing advisor for a mental health trust and I wish to bring two matters to your attention. The first is an adverse reaction report issueing Product A where The patient is a 52 year old male with hepatitis C. He deve... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the subject developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention taken, qualifyin... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Compliance Team,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. I have two distinct concerns to raise. The first is an adverse reac... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the subject complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinic... |
SUBJECT: Cross-product clinical and quality note on Product A and supply inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the nurse practitioner in a busy GP practice and I have two distinct issues to address. The first problems Product A where The patient is a 82 year old female with osteoarthritis. She reported hal... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient reported hallucinations and confusion beginning on day 4 of the regimen temporally associated with Product A initiation, with clinical intervention ... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Clinical Affairs,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I wish to raise two issues. The first concerns medical information about Produc... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Medical and Commercial Teams,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. and I am formally reporting two concerns. The first is a s... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Urgent concern regarding Product A and institutional inquiry
BODY:
Dear Post-Market Surveillance,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically What adverse reactions... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in the ref... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Medical Affairs,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I am writing to formally report two distinct matter... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you provide guidance on dose ... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Healthcare Liaison,
I am the clinical pharmacy specialist in a busy emergency department and I am contacting you regarding two separate topics. The first is a product defect report for Product A where a tablet was ob... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where a tablet was observed to be split into 2 unequal fragments inside an intact blister cavity in a specific identified batch with quaranti... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
To Whom It May Concern,
I am the nurse practitioner in a busy GP practice and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What is the bioequivalence data for the... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the bioequivalence data for the gene... |
SUBJECT: Supply and experience review of Product A and institutional inquiry
BODY:
Dear Pharmacy Director,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Does Product A h... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A have any known interaction wi... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the clinical pharmacy specialist in a busy emergency department and I have two distinct issues to address. Regarding Product A for formulary evaluation, Can you confirm the shelf life and beyond... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and beyond-us... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Pharmacy Director,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I need to address two issues simultaneously. The first is a medical... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am writing to raise two distinct concerns. The first is a clinical information r... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there a black box warning or regu... |
SUBJECT: Complex issue involving Product A and supply inquiry
BODY:
Dear Medical Affairs,
I am the lead clinical coordinator for a hospice network and I have two distinct issues to address. The first concerns Product A where The patient is a 42 year old female with gestational diabetes at 24 weeks. She complained of s... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am writing as the clinical coordinator for a multi-site renal network and I have two distinct issues to address. The first issues Product A where The patient is a 26 year old female with epilepsy. She reported severe mu... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient reported severe muscle pain with elevated creatine kinase levels on day 9 temporally associated with Product A initiation, with clinical interventio... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Quality Officer,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. and I am writing to formally raise t... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there a black box warning or regu... |
SUBJECT: Administrative and medical query on Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am writing as the clinical coordinator for a multi-site renal network and I have two distinct issues to address. The first concerns Product A where The patient is a 32 year old female with antiphospholipid sy... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Compliance Team,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I am writing to report two separate issues. The first involves Product A where The pati... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention and ... |
SUBJECT: Healthcare provider memo on Product A and institutional inquiry
BODY:
Dear Clinical Affairs,
I am writing as the clinical coordinator for a multi-site renal network and I have two distinct issues to address. Regarding Product A for formulary evaluation, What are the infusion instructions if Product A is admin... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the infusion instructions if Produc... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Compliance Team,
I am the prescribing advisor for a mental health trust and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Can you clarify whether Product A is indicated as fir... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is indicat... |
SUBJECT: Clinical observation with Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspec... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the label on the outer carton displayed an incorrect batch number compared to the inner foil strip in a specific identified batch with ... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Patient Support,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. I have two separate matters to raise. Firstly regarding Product A I... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy cate... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Regulatory Affairs,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I wish to raise two issues simultaneously. The first is an adverse event report ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention and ... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Medical Information and Safety Team,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease managemen... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you provide guidance on dose ... |
SUBJECT: Packaging defect and dosing question for Product A and institutional contract enquiry
BODY:
Dear Quality and Commercial Teams,
I am the clinical pharmacy specialist in a busy emergency department and I have two distinct issues to address. The first concerns Product A 20mg where our quality team found that the... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the inhaler canister appeared dented and the counter mechanism was frozen at 0 doses remaining in a specific identified batch with quar... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Quality Assurance Team,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am writing to report two separate issues. The first invo... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the individual experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clin... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Pharmacy Director,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. I have two distinct concerns to raise. The first is an ad... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinica... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I am contacting you about two separate matters. The first is a req... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Clinical observation with Product A and supply inquiry
BODY:
Dear Compliance Team,
I am the clinical lead at a geriatric medicine service and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 55 year old female with a history of migraine. She was s... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient documented dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical intervention ta... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Compliance Team,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I need to bring two matters to your attention. Regarding Product A The patient is a 73 ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I need t... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Please provide the recommended stor... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. and I am contacting you about... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you provide guidance on dose ... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Medical Affairs,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I need to address two issues simultaneously. The first is a medical inf... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What adverse reactions are listed i... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. and I am writing to formally raise two matters. ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and b... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Patient Support,
I am the nurse practitioner in a busy GP practice and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The individual is a 33 year old female with multiple ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the subject developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical intervention t... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Compliance Team,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am writing to raise two distinct matters. The first is a clinical i... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recom... |
SUBJECT: Market access and subject impact of Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am writing as the clinical coordinator for a multi-site renal network and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 50 year old male ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Patient Support,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I need to bring two matters to yo... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
Dear Clinical Coordinator,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medica... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recommended d... |
SUBJECT: Patient feedback concerning Product A and supply inquiry
BODY:
Dear Medical Affairs,
I am the lead clinical coordinator for a hospice network and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 39 year old female with fibromyal... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Medical and Commercial Teams,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I am formally reporting two concerns. The first is a safety issue with... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clini... |
SUBJECT: Unexpected reaction linked to Product A and Product B
BODY:
Dear Pharmacovigilance Team,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am contacting you about two separate matters. The first is a reque... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Pharmacovigilance Team,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I wish to raise two issues simultaneously. The first is an adverse event ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.